Jeevan Scientific Technology Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | - |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 12 | 4.76 | -- | -- |
| Op profit growth | 11.40 | 73.80 | -- | -- |
| EBIT growth | (8.30) | 62 | -- | -- |
| Net profit growth | (88) | (13,597) | -- | -- |
| Profitability ratios (%) | ||||
| OPM | 16.80 | 16.80 | 10.20 | -- |
| EBIT margin | 10.90 | 13.30 | 8.58 | -- |
| Net profit margin | 0.55 | 4.96 | -- | -- |
| RoCE | 6.67 | 11.90 | -- | -- |
| RoNW | 0.14 | 2.19 | -- | -- |
| RoA | 0.08 | 1.11 | -- | -- |
| Per share ratios () | ||||
| EPS | 0.10 | 0.97 | -- | -- |
| Dividend per share | -- | -- | -- | -- |
| Cash EPS | (1.80) | (0.30) | (1.10) | -- |
| Book value per share | 19.20 | 18.20 | 6.24 | -- |
| Valuation ratios | ||||
| P/E | 417 | 41.50 | -- | -- |
| P/CEPS | (24) | (116) | (34) | -- |
| P/B | 2.17 | 2.22 | 6.22 | -- |
| EV/EBIDTA | 15 | 12.50 | 15.80 | -- |
| Payout (%) | ||||
| Dividend payout | -- | -- | -- | -- |
| Tax payout | (69) | (11) | (103) | -- |
| Liquidity ratios | ||||
| Debtor days | 247 | 186 | -- | -- |
| Inventory days | 5.10 | 27.60 | -- | -- |
| Creditor days | (79) | (74) | -- | -- |
| Leverage ratios | ||||
| Interest coverage | (1.20) | (1.70) | (1.20) | -- |
| Net debt / equity | 0.79 | 0.49 | 2.88 | -- |
| Net debt / op. profit | 5.08 | 2.67 | 6.16 | -- |
| Cost breakup () | ||||
| Material costs | (6.40) | (0.90) | (0.90) | -- |
| Employee costs | (28) | (12) | (20) | -- |
| Other costs | (49) | (70) | (69) | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | - |
|---|---|---|---|---|
| Revenue | 20.40 | 18.20 | 17.40 | -- |
| yoy growth (%) | 12 | 4.76 | -- | -- |
| Raw materials | (1.30) | (0.20) | (0.20) | -- |
| As % of sales | 6.37 | 0.87 | 0.87 | -- |
| Employee costs | (5.70) | (2.30) | (3.60) | -- |
| As % of sales | 27.80 | 12.40 | 20.40 | -- |
| Other costs | (10) | (13) | (12) | -- |
| As % of sales | 49 | 69.90 | 68.50 | -- |
| Operating profit | 3.42 | 3.07 | 1.77 | -- |
| OPM | 16.80 | 16.80 | 10.20 | -- |
| Depreciation | (2.10) | (1.20) | (0.70) | -- |
| Interest expense | (1.90) | (1.40) | (1.30) | -- |
| Other income | 0.92 | 0.58 | 0.40 | -- |
| Profit before tax | 0.36 | 1.01 | 0.22 | -- |
| Taxes | (0.30) | (0.10) | (0.20) | -- |
| Tax rate | (69) | (11) | (103) | -- |
| Minorities and other | -- | -- | -- | -- |
| Adj. profit | 0.11 | 0.90 | -- | -- |
| Exceptional items | -- | -- | -- | -- |
| Net profit | 0.11 | 0.90 | -- | -- |
| yoy growth (%) | (88) | (13,597) | -- | -- |
| NPM | 0.55 | 4.96 | -- | -- |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | - |
|---|---|---|---|---|
| Profit before tax | 0.36 | 1.01 | 0.22 | -- |
| Depreciation | (2.10) | (1.20) | (0.70) | -- |
| Tax paid | (0.30) | (0.10) | (0.20) | -- |
| Working capital | 6.90 | -- | -- | -- |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | 4.89 | (0.30) | -- | -- |
| Capital expenditure | 23.30 | -- | -- | -- |
| Free cash flow | 28.20 | (0.30) | -- | -- |
| Equity raised | 13.60 | 14.30 | -- | -- |
| Investments | -- | -- | -- | -- |
| Debt financing/disposal | 12.60 | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | 54.40 | 14 | -- | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Equity capital | 15.30 | 14.60 | 14 | 6.04 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 16.50 | 7.42 | 2.84 | (2.30) |
| Net worth | 31.80 | 22 | 16.90 | 3.77 |
| Minority interest | ||||
| Debt | 18.20 | 18.80 | 8.45 | 11.10 |
| Deferred tax liabilities (net) | 0.40 | 0.26 | 0.11 | 0.22 |
| Total liabilities | 50.40 | 41.10 | 25.40 | 15.10 |
| Fixed assets | 32.60 | 28.20 | 16.40 | 8.67 |
| Intangible assets | ||||
| Investments | -- | -- | -- | -- |
| Deferred tax asset (net) | -- | 0.12 | 0.22 | 0.45 |
| Net working capital | 14.10 | 11.30 | 8.62 | 5.74 |
| Inventories | 0.23 | 0.10 | 0.47 | 2.28 |
| Inventory Days | -- | 1.79 | 9.42 | 47.90 |
| Sundry debtors | 14.70 | 16.30 | 11.30 | 7.24 |
| Debtor days | -- | 292 | 227 | 152 |
| Other current assets | 10.10 | 3.38 | 2.38 | 1.78 |
| Sundry creditors | (4.40) | (4.60) | (2.70) | (3.40) |
| Creditor days | -- | 82.50 | 54.10 | 72 |
| Other current liabilities | (6.50) | (3.80) | (2.90) | (2.10) |
| Cash | 3.67 | 1.42 | 0.26 | 0.21 |
| Total assets | 50.40 | 41.10 | 25.50 | 15.10 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 |
|---|---|---|---|---|---|
| Gross Sales | 16.90 | 21.80 | 16.10 | 12.90 | 13.60 |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 16.90 | 21.80 | 16.10 | 12.90 | 13.60 |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 0.92 | 0.90 | 0.65 | 0.30 | 0.24 |
| Total Income | 17.80 | 22.70 | 16.70 | 13.20 | 13.80 |
| Total Expenditure ** | 16.50 | 15.70 | 13.40 | 10.80 | 11.30 |
| PBIDT | 1.25 | 6.97 | 3.32 | 2.40 | 2.55 |
| Interest | 2.04 | 1.55 | 1.51 | 1.01 | 0.80 |
| PBDT | (0.80) | 5.42 | 1.81 | 1.39 | 1.74 |
| Depreciation | 2.99 | 2.43 | 1.51 | 0.86 | 0.41 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | (0.70) | 0.39 | 0.07 | 0.12 | 0.27 |
| Deferred Tax | -- | -- | -- | -- | -- |
| Reported Profit After Tax | (3.10) | 2.61 | 0.22 | 0.41 | 1.06 |
| Minority Interest After NP | -- | -- | -- | -- | -- |
| Net Profit after Minority Interest | (3.10) | 2.61 | 0.22 | 0.41 | 1.06 |
| Extra-ordinary Items | -- | -- | -- | (0.10) | -- |
| Adjusted Profit After Extra-ordinary item | (3.10) | 2.61 | 0.22 | 0.50 | 1.06 |
| EPS (Unit Curr.) | (2.10) | 1.71 | 0.24 | 0.51 | 1.75 |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 15.30 | 15.30 | 9.28 | 8.11 | 6.04 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 7.41 | 32 | 20.60 | 18.60 | 18.80 |
| PBDTM(%) | (4.70) | 24.90 | 11.20 | 10.80 | 12.80 |
| PATM(%) | (18) | 12 | 1.37 | 3.17 | 7.79 |
